Asthma treatment has evolved significantly in recent years, with a growing focus on preventing symptoms rather than simply relieving them. While salbutamol (often recognised as the familiar blue reliever inhaler) remains an important treatment for many people, healthcare guidance now encourages the use of combination inhalers for suitable patients to help reduce the risk of asthma attacks. Unlike a reliever inhaler that temporarily eases symptoms, combination inhalers contain medicines that help control the underlying inflammation that causes asthma flare-ups. Research has shown that relying too heavily on a salbutamol inhaler alone may increase the risk of severe asthma attacks, which is why many healthcare professionals now recommend reviewing treatment if a reliever inhaler is needed frequently. For those who currently use a salbutamol inhaler, this doesn't mean it is no longer effective or appropriate. Instead, it highlights the importance of having regular asthma reviews with a healthcare professional to ensure your treatment plan continues to meet your needs. If you find yourself using your reliever inhaler several times each week, it may be worth discussing whether a combination inhaler could offer better long-term asthma control. If you have already been diagnosed with asthma by your GP, you may be able to complete an online consultation with Medical Specialists Online Pharmacy to access appropriate asthma treatment. Following a clinical assessment, eligible patients can choose from a wide range of asthma medications, including salbutamol reliever inhalers, combination inhalers and other commonly prescribed treatments, depending on their individual needs. Whether you currently use a salbutamol inhaler or are interested in exploring other treatment options, this latest guidance highlights the importance of reviewing your asthma regularly. By understanding the different inhalers available and seeking the right treatment when needed, you can work towards better long-term asthma control and reduce the risk of future asthma attacks.